Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005759 | mitochondrial matrix | 5 | 11 |
GO:0031974 | membrane-enclosed lumen | 2 | 11 |
GO:0043233 | organelle lumen | 3 | 11 |
GO:0070013 | intracellular organelle lumen | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A4HGX4
Term | Name | Level | Count |
---|---|---|---|
GO:0006950 | response to stress | 2 | 11 |
GO:0006974 | DNA damage response | 4 | 11 |
GO:0006996 | organelle organization | 4 | 11 |
GO:0007005 | mitochondrion organization | 5 | 11 |
GO:0007006 | mitochondrial membrane organization | 5 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016043 | cellular component organization | 3 | 11 |
GO:0033554 | cellular response to stress | 3 | 11 |
GO:0046902 | regulation of mitochondrial membrane permeability | 4 | 11 |
GO:0050896 | response to stimulus | 1 | 11 |
GO:0051716 | cellular response to stimulus | 2 | 11 |
GO:0061024 | membrane organization | 4 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0065008 | regulation of biological quality | 2 | 11 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
GO:0090559 | regulation of membrane permeability | 3 | 11 |
GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death | 5 | 11 |
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 83 | 87 | PF00656 | 0.517 |
CLV_NRD_NRD_1 | 239 | 241 | PF00675 | 0.463 |
CLV_NRD_NRD_1 | 262 | 264 | PF00675 | 0.456 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.267 |
CLV_NRD_NRD_1 | 287 | 289 | PF00675 | 0.577 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.615 |
CLV_PCSK_KEX2_1 | 239 | 241 | PF00082 | 0.463 |
CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.424 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.267 |
CLV_PCSK_KEX2_1 | 287 | 289 | PF00082 | 0.573 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.584 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.393 |
CLV_PCSK_PC1ET2_1 | 80 | 82 | PF00082 | 0.302 |
CLV_PCSK_PC7_1 | 2 | 8 | PF00082 | 0.648 |
CLV_PCSK_PC7_1 | 283 | 289 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.340 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.456 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.677 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.639 |
DOC_CYCLIN_RxL_1 | 2 | 12 | PF00134 | 0.566 |
DOC_MAPK_gen_1 | 239 | 247 | PF00069 | 0.512 |
DOC_MAPK_gen_1 | 262 | 271 | PF00069 | 0.320 |
DOC_PP1_RVXF_1 | 153 | 159 | PF00149 | 0.318 |
DOC_PP4_FxxP_1 | 33 | 36 | PF00568 | 0.375 |
DOC_PP4_FxxP_1 | 74 | 77 | PF00568 | 0.380 |
DOC_WW_Pin1_4 | 247 | 252 | PF00397 | 0.378 |
DOC_WW_Pin1_4 | 256 | 261 | PF00397 | 0.377 |
DOC_WW_Pin1_4 | 272 | 277 | PF00397 | 0.240 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.459 |
DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.531 |
LIG_14-3-3_CanoR_1 | 175 | 181 | PF00244 | 0.365 |
LIG_14-3-3_CanoR_1 | 190 | 195 | PF00244 | 0.329 |
LIG_14-3-3_CanoR_1 | 81 | 85 | PF00244 | 0.531 |
LIG_14-3-3_CterR_2 | 287 | 289 | PF00244 | 0.424 |
LIG_deltaCOP1_diTrp_1 | 223 | 230 | PF00928 | 0.361 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.541 |
LIG_FHA_1 | 265 | 271 | PF00498 | 0.322 |
LIG_FHA_1 | 53 | 59 | PF00498 | 0.429 |
LIG_FHA_2 | 110 | 116 | PF00498 | 0.567 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.424 |
LIG_LIR_Apic_2 | 32 | 36 | PF02991 | 0.405 |
LIG_LIR_Apic_2 | 55 | 60 | PF02991 | 0.468 |
LIG_LIR_Apic_2 | 73 | 77 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 102 | 110 | PF02991 | 0.502 |
LIG_LIR_Nem_3 | 258 | 264 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 76 | 82 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 98 | 103 | PF02991 | 0.334 |
LIG_PALB2_WD40_1 | 74 | 82 | PF16756 | 0.348 |
LIG_PCNA_PIPBox_1 | 89 | 98 | PF02747 | 0.396 |
LIG_Pex14_1 | 53 | 57 | PF04695 | 0.446 |
LIG_Pex14_2 | 74 | 78 | PF04695 | 0.378 |
LIG_SH2_CRK | 103 | 107 | PF00017 | 0.432 |
LIG_SH2_PTP2 | 214 | 217 | PF00017 | 0.416 |
LIG_SH2_PTP2 | 57 | 60 | PF00017 | 0.428 |
LIG_SH2_STAP1 | 103 | 107 | PF00017 | 0.272 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.365 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.428 |
LIG_SH3_3 | 142 | 148 | PF00018 | 0.342 |
LIG_SH3_3 | 15 | 21 | PF00018 | 0.489 |
LIG_SH3_3 | 194 | 200 | PF00018 | 0.452 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.459 |
LIG_SUMO_SIM_anti_2 | 126 | 133 | PF11976 | 0.319 |
LIG_SUMO_SIM_anti_2 | 202 | 208 | PF11976 | 0.403 |
LIG_TRAF2_1 | 37 | 40 | PF00917 | 0.530 |
MOD_CDK_SPxK_1 | 247 | 253 | PF00069 | 0.441 |
MOD_CDK_SPxK_1 | 256 | 262 | PF00069 | 0.348 |
MOD_CDK_SPxxK_3 | 256 | 263 | PF00069 | 0.437 |
MOD_CK1_1 | 102 | 108 | PF00069 | 0.491 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.396 |
MOD_CK1_1 | 130 | 136 | PF00069 | 0.490 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.415 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.397 |
MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.435 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.390 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.351 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.386 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.422 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.527 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.411 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.351 |
MOD_NEK2_1 | 264 | 269 | PF00069 | 0.393 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.356 |
MOD_PKA_1 | 80 | 86 | PF00069 | 0.393 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.407 |
MOD_PKA_2 | 80 | 86 | PF00069 | 0.537 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.424 |
MOD_Plk_1 | 224 | 230 | PF00069 | 0.234 |
MOD_Plk_1 | 264 | 270 | PF00069 | 0.364 |
MOD_Plk_2-3 | 61 | 67 | PF00069 | 0.429 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.404 |
MOD_Plk_4 | 127 | 133 | PF00069 | 0.462 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.643 |
MOD_Plk_4 | 20 | 26 | PF00069 | 0.460 |
MOD_Plk_4 | 241 | 247 | PF00069 | 0.496 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.460 |
MOD_ProDKin_1 | 247 | 253 | PF00069 | 0.384 |
MOD_ProDKin_1 | 256 | 262 | PF00069 | 0.376 |
MOD_ProDKin_1 | 272 | 278 | PF00069 | 0.245 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.456 |
MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.529 |
MOD_SUMO_rev_2 | 39 | 49 | PF00179 | 0.441 |
TRG_DiLeu_BaEn_1 | 202 | 207 | PF01217 | 0.370 |
TRG_DiLeu_BaEn_1 | 67 | 72 | PF01217 | 0.333 |
TRG_DiLeu_BaEn_4 | 67 | 73 | PF01217 | 0.356 |
TRG_DiLeu_BaLyEn_6 | 4 | 9 | PF01217 | 0.676 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.386 |
TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.302 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.366 |
TRG_ENDOCYTIC_2 | 96 | 99 | PF00928 | 0.355 |
TRG_ER_diArg_1 | 219 | 222 | PF00400 | 0.448 |
TRG_ER_diArg_1 | 238 | 240 | PF00400 | 0.425 |
TRG_ER_diArg_1 | 261 | 263 | PF00400 | 0.473 |
TRG_ER_diArg_1 | 282 | 284 | PF00400 | 0.469 |
TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.649 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HYL5 | Leptomonas seymouri | 75% | 99% |
A0A0S4JCJ0 | Bodo saltans | 48% | 89% |
A0A1X0NR19 | Trypanosomatidae | 60% | 100% |
A0A3Q8IE10 | Leishmania donovani | 85% | 100% |
A4I404 | Leishmania infantum | 85% | 100% |
D0A901 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9B094 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4Q7Z1 | Leishmania major | 84% | 100% |
V5B945 | Trypanosoma cruzi | 56% | 100% |